FDA grants client first-time approval on insomnia drug

Hogan Lovells client Transcept Pharmaceuticals, Inc. announced on 23 November 2011 U.S. Food and Drug Administration (FDA) approval of Intermezzo® (zolpidem tartrate sublingual tablet) – the first drug product cleared by the FDA to treat patients suffering from middle-of-the-night insomnia.

Read "FDA grants client first-time approval on insomnia drug"


Download PDF Share Back To Listing
Loading data